Received Dec 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
after vaccination he hasn't been able to work for three years; This spontaneous case was reported by a consumer and describes the occurrence of IMPAIRED WORK ABILITY (after vaccination he hasn't been able to work for three years) in a male patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced IMPAIRED WORK ABILITY (after vaccination he hasn't been able to work for three years) (seriousness criterion medically significant). At the time of the report, IMPAIRED WORK ABILITY (after vaccination he hasn't been able to work for three years) had not resolved. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. No concomitant medications were reported. It was reported that, the reporter was asking why Moderna developed a vaccine that was gene therapy. The patient was reported to be healthy but after vaccination he had not been able to work for three years. It was unknown if the patient experienced any additional symptoms/events. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2025-792490 (E2B Linked Report).; Reporter's Comments: Company comment: The benefit-risk relationship of product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-792490:Same reporter case